Výsledky vyhledávání - "Breast Neoplasms/*drug therapy/*mortality/pathology"

Palliative chemotherapy in elderly patients with common metastatic malignancies: A Hellenic Cooperative Oncology Group registry analysis of management, outcome and clinical benefit predictors

Autor: Pentheroudakis, George, Fountzilas, George, Kalofonos, H. P., Golfinopoulos, Vassilis, Aravantinos, Gerasimos, Bafaloukos, Dimitrios, Papakostas, P., Pectasides, Dimitrios, Christodoulou, C., Syrigos, K., Economopoulos, T., Pavlidis, Nicholas

Publikováno v: Critical reviews in oncology/hematology

Introduction: Cancer in the elderly is a common health issue in developed societies. We sought to present epidemiology, management and outcome data on fit elderly patients with common metastatic cancers and to identify predictors of clinical benefit

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f794ff0223e22b7ee8c6f4905ddf3c2c
https://pubmed.ncbi.nlm.nih.gov/18243010

Zobrazit plný text záznamu

Metastatic breast cancer with liver metastases: a registry analysis of clinicopathologic, management and outcome characteristics of 500 women

Autor: Pentheroudakis, George, Fountzilas, George, Bafaloukos, Dimitrios, Koutsoukou, V., Pectasides, Dimitrios, Skarlos, Dimosthenis V., Samantas, E., Kalofonos, H. P., Gogas, H., Pavlidis, Nicholas

Publikováno v: Breast cancer research and treatment

Introduction. Breast cancer patients developing liver metastases have traditionally been considered to make up a poor prognosis group with median survival rates of less than 6 months. We retrospectively analysed clinicopathologic characteristics of 5

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a1638f5225cdcc8746331a2ca1d9f66c
https://pubmed.ncbi.nlm.nih.gov/16322882

Zobrazit plný text záznamu

Cyclophosphamide, mitoxantrone, fluorouracil versus conventional CMF as adjuvant treatment in node-positive breast cancer patients. A Hellenic Cooperative Oncology Group Study

Publikováno v: Oncology. 53(2)

362 evaluable node-positive patients with stage II breast cancer were randomized, receiving either 6 cycles of conventional CMF or 6 cycles of the combination of cyclophosphamide (500 mg/m2), mitoxantrone (Novantrone 10 mg/m2), and fluorouracil (500

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::115c7566d35e282d647216d1e4a1b440
https://pubmed.ncbi.nlm.nih.gov/8604240

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání